NCT06487026View on ClinicalTrials.gov

Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study

NANot yet recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions
Bone Metastases
Interventions
DEVICE

ArcBlate Focused Ultrasound Ablation System

MR-guided High Intensity Focused Ultrasound (MRgHIFU)

Trial Locations (4)

100

National Taiwan University Hospital, Taipei

220

Far Eastern Memorial Hospital, New Taipei City

333

Chang Gung Memorial Hospital - Linkou, Taoyuan District

407

Taichung Veterans General Hospital, Taichung

Sponsors

Lead Sponsor

EpiSonica
All Listed Sponsors
lead

EpiSonica

INDUSTRY